GVK BIO is a global Contract Research & Development Organization (CRDO) providing Drug Discovery and Development services to the biopharma industry. Established in 2001, GVK BIO for over 16 years has supported the Research and Development programs of innovator drug companies enabling them to bring their products to market quicker and cost- effectively.
We are a team of over 2000 highly qualified scientists, backed by well-defined and scalable processes, modern facilities and a strong customer-centric partnering approach. Our distinctiveness comes from our expertise in the breadth and depth of services that we provide in drug discovery and development. We recognize that our clients’ needs are diverse, and we have designed our services accordingly. GVK BIO’s capabilities include Integrated Drug Discovery, Chemistry, Biology, Large molecule R&D , Chemical Development, Formulation & Analytical development, Contract Manufacturing and Drug Repurposing.
Spread across 55 acres of land, GVK BIO has 6 state-of-the-art research facilities, 5 in India and one in Morgan Hill, California. All our facilities confirm to stringent regulatory standards. Our infrastructure has a built-up area of 1,200,000 square feet, housing chemistry & biology labs, AAALAC accredited animal house, analytical labs, formulation development labs, kilo labs, pilot plants and manufacturing facilities. GVK BIO has been inspected by all the leading regulatory agencies of the world including USFDA, WHO, PMDA, EDQM and EMEA.
In 2014, GVK BIO acquired Aragen Bioscience, Inc., a US-based preclinical CRO specializing in biologics services, thereby enabling clients access an integrated R&D services platform across both large and small molecules.
GVK BIO recognizes its commitment to the community in which it operates through its Corporate Social Responsibility initiatives. We reach out to underserved communities and work towards making a meaningful difference to them. GVK BIO’s CSR programs are focused on education, health, environment and women empowerment.